SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chih, D. Y. Articles by Koeffler, H. P. Search for Related Content PubMed PubMed Citation Articles by Chih, D. Y. Articles by Koeffler, H. P. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, Vol. 90 No. 8 (October 15), 1997: pp. 2987-2994 Modulation of mRNA Expression of a Novel Human Myeloid-Selective CCAAT/Enhancer Binding Protein Gene (C/EBP) By Doris Y. Chih, Alexey M. Chumakov, Dorothy J. Park, Agnes G. Silla, and H. Phillip Koeffler From the Division of Hematology/Oncology, Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA.     ABSTRACT Abstract Introduction Methods Results Discussion References Human C/EBP is a newly cloned gene coding for a CCAAT/enhancer binding protein that may be involved in the regulation of myeloid differentiation. Our studies showed that levels of C/EBP mRNA were markedly increased in NB4 cells (promyelocytic leukemia line), because they were induced by 9-cis retinoic acid (9-cis RA) to differentiate towards granulocytes. Accumulation of C/EBP mRNA occurred as early as 1 hour after exposure of NB4 cells to 9-cis RA (5 × 10-7 mol/L); and at 48 hours, levels were increased by 5.1-fold. Dose-response studies showed that 10-7 to 10-6 mol/L 9-cis RA (12 hours) resulted in peak levels of C/EBP mRNA; but even 10-10 mol/L 9-cis RA increased levels of these transcripts. NB4 cells pulse-exposed (30 minutes) to all-trans retinoic acid (ATRA), washed, and cultured (3 days) with either dimethylsulfoxide (DMSO) or hexamethylene bisacetamide (HMBA) had a prominent increase in levels of C/EBP mRNA and an increase in granulocytic differentiation, but exposure to either DMSO or HMBA alone had no effect on base levels of C/EBP and did not induce differentiation. Macrophage-differentiation of NB4 reduced levels of C/EBP mRNA. Nuclear run-off assays and half-life studies showed that accumulation of C/EBP mRNA by 9-cis RA was due to enhanced transcription. Furthermore, this C/EBP mRNA accumulation did not require synthesis of new protein factors because 9-cis RA induced C/EBP mRNA accumulation in the absence of new protein synthesis. ATRA also induced expression of C/EBP protein in NB4 cells, as shown by Western blotting. In contrast to the increase of C/EBP in 9-cis RA-mediated granulocytic differentiation, the DMSO-induced differentiation of HL-60 cells down the granulocytic pathway was associated with an initial reduction of C/EBP mRNA levels. In summary, we have discovered that expression of C/EBP mRNA is markedly enhanced as the NB4 promyelocytes are induced by retinoids to differentiate towards granulocytes. This induction of C/EBP mRNA expression is transcriptionally mediated and occurs in the absence of synthesis of additional protein factors. We suspect that the C/EBP promoter/enhancer contains a retinoic acid-response element that is directly stimulated by retinoids.     INTRODUCTION Abstract Introduction Methods Results Discussion References HEMATOPOIETIC CELLS committed to the myeloid lineage progress through a complex series of differentiation steps before reaching the morphologically and functionally distinct end-stage of macrophages and neutrophils. While differentiating, these cells are continually reprogrammed to express stage-specific genes through the activation of regulatory transcription factors.1-4 Consequently, as studies on myeloid genes suggest, transcription factors play a critical role in myelopoiesis and untimely transcriptional activity may result in a failure to differentiate and promote leukemic growth.5-7 To understand the process of normal myeloid differentiation, identification and characterization of the important regulatory factors integral to the myeloid lineage are important. Members of the C/EBP family of transcription factors have been implicated in a number of developmental and growth regulatory processes in several cell types.8-11 In the hematopoietic system, C/EBP-, -, and - showed a coordinated pattern of expression in differentiating myeloid cells and appeared to play decisive roles in myelopoiesis.12 These three C/EBP isoforms also collaborated with the Myb oncoprotein to induce the expression of myeloid-specific target genes, even in cells of heterologous tissues such as erythroblasts or fibroblasts.4 Expression of C/EBP- was found to parallel the differentiation of myeloid cells to macrophages.12 Furthermore, mice containing a homozygous null mutation of either the C/EBP- or the C/EBP- were found to be defective in either macrophage functions or granulocyte development, respectively.13,14 Another C/EBP-like factor, C/EBP-, was found to be expressed ubiquitously15 and cooperated with Fos to bind to positive regulatory element-I (PRE-I), which is a strong enhancer element essential for the expression of the human interleukin-4-encoding gene.16 Recently, we and others have isolated another member of the C/EBP family of transcription factors, C/EBP.17,18 This gene has two exons and encodes a nuclear phosphoprotein of 32 kD.18 The DNA sequence analysis of C/EBP shows that the gene encodes a protein highly homologous to rat CRP1.17 Similar to other C/EBP isoforms, C/EBP binds to a consensus C/EBP binding site.19,20 Remarkably, C/EBP shows a restricted expression in cells of the myeloid lineage, especially during their differentiation toward granulocytes.17,18 Expression studies of this gene showed that it is expressed independently of other C/EBP proteins. Such a restricted pattern of expression suggests greatly that the gene may play an important role in the regulation of myelopoiesis. Therefore, in the present study, we examine the regulation of C/EBP expression during differentiation of myeloid cells by culturing several myeloid cell lines with various differentiating agents. Our data suggest that the expression of C/EBP is closely associated with the retinoid-mediated differentiation of early myeloid cells to granulocytes and that this expression is controlled by transcriptional mechanisms in the absence of new protein synthesis.     MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Cells and culture conditions. HL-60 cells were obtained from the American Tissue Culture Collection (Rockville, MD). NB4 cells were generously provided by M. Lanotte (St Louis Hospital, Paris, France). Cells were grown in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin (GIBCO/BRL, Gaithersburg, MD). Cell viability was determined in all experimental procedures using trypan blue exclusion. Chemicals. All-trans retinoic acid (ATRA; Sigma, St Louis, MO) was dissolved in 95% (vol/vol) ethanol to a stock concentration of 10-2 mol/L and stored at -70°C. 9-cis retinoic acid (9-cis RA; kindly provided by M. Dawson, Stanford Research Institute, Palo Alto, CA) was dissolved in 95% ethanol to a stock concentration of 10-2 mol/L and stored at -70°C. The physiologically active vitamin D compound, 1,25 dihydroxyvitamin D3 [1,25(OH)2D3 , vit D3 ; generously provided by M. Uskokovic, Hoffmann La Roche, Nutley, NJ] was dissolved in 100% ethanol at a stock concentration of 10-3 mol/L and stored at -20°C. 12-O-tetradecanoylphorbol 12-acetate (TPA; Sigma) was dissolved in 100% acetone to a stock concentration of 10-4 mol/L and kept at -20°C. Dimethylsulfoxide (DMSO) and hexamethylene bisacetamide (HMBA) were purchased from Sigma. Actinomycin-D (Sigma) was dissolved in 20% (vol/vol) ethanol to a stock concentration of 1 mg/mL. Cycloheximide (CHX; Sigma) was dissolved in 1× phosphate-buffered saline (GIBCO/BRL) to a stock concentration of 2 mg/mL and stored at -20°C. View larger version (43K): [in this window] [in a new window]   View larger version (43K): [in this window] [in a new window]   Fig 1. (A) Time-response: C/EBP mRNA expression in NB4 cells cultured with 9-cis RA. Northern blot with total RNA (30 µg/lane) of NB4 exposed for various lengths of time to 9-cis RA (5 × 10-7 mol/L) and probed with full-length C/EBP cDNA. The bottom panel shows ethidium bromide-staining of the 28S and 18S rRNA on the gel as assessment of RNA quantities in each lane. Fold-inductions were calculated by the ratio of densitometry readings of C/EBP to -actin. (B) Dose-response: C/EBP mRNA levels in NB4 cells treated with 9-cis RA. Northern blot of total RNA (30 µg/lane) of NB4 cells exposed to various concentrations of ATRA for 12 hours and hybridized with full-length C/EBP cDNA probe. The bottom panel shows hybridization with the -actin probe as assessment of RNA quantities in each lane. Fold-inductions were calculated by the ratio of densitometry readings of C/EBP to -actin. Induction of differentiation. ATRA-priming was performed by incubating the NB4 cells with 10-7 mol/L of ATRA for 30 minutes. The cells were then washed twice in culture medium without ATRA and reincubated with various differentiating agents for 3 days. To stop protein synthesis, NB4 cells were pretreated for 30 minutes with 10 µg/mL CHX and then induced with 5 × 10-7 mol/L 9-cis RA. For analysis of RNA stability, NB4 cells were treated with actinomycin D (10 µg/mL) with or without a previous 12 hours of exposure to 9-cis RA (5 × 10-7 mol/L). ATRA and 9-cis RA were used interchangeably because they had similar biologic activities. Differentiation of cell lines was assessed by the ability of the cells to produce superoxide as measured by reduction of nitroblue tetrazolium (NBT)21 and by analysis of the membrane-bound differentiation marker, CD11b, using one- and two-color immunofluorescence. The latter was performed as described.22 Briefly, cells were incubated at 4°C for 60 minutes in 10% human AB serum (Sigma) to block Fc receptors and then stained with fluorescein isothiocyanate (FITC)-conjugated murine monoclonal antibody (Becton Dickinson, Mountain View, CA). Control samples were incubated with FITC-conjugated mouse IgG1 isotype control (Becton Dickinson). Analysis of fluorescence was performed on a FACScan flow cytometry, using a LYSIS II program (Becton Dickinson). RNA isolation and Northern blot analysis. Total RNA was extracted using Trizol (GIBCO/BRL) according to the manufacturer's instructions. Twenty to 30 µg of total RNA was electrophoresed on 1.1% agarose gel containing MOPS and formaldehyde and transferred onto nitrocellulose membranes (MSI, Westboro, MA) as described.23 Blots were hybridized for 16 to 24 hours at 42°C in 50% formamide, 5× SSC, 5× Denhardt's, 0.1% sodium dodecyl sulfate (SDS), and 100 µg/mL salmon sperm DNA (Sigma) plus 3 × 106 cpm/mL of the full-length C/EBP cDNA probe after labeling with -32P-dCTP by random primer DNA-labeling system (Stratagene, La Jolla, CA). Filters were washed to a stringency of 0.1× SSC at 65°C and exposed to Kodak Biomax film (Eastman Kodak, New Haven, CT). Radioactive counts were measured through Ambis Core Software, Version 4.0 according to the manufacturer's instructions (CSPI, Billerica, MA). Fold-inductions were calculated by the ratio of radioactive counts of C/EBP to -actin. View larger version (36K): [in this window] [in a new window]   Fig 2. Regulation of C/EBP expression in NB4 cells induced to differentiate after ATRA-priming. Northern blot of total RNA (30 µg/lane) from NB4 cells treated with various differentiating agents for 3 days with or without 30 minutes of priming with 1 × 10-7 mol/L ATRA. The top panel shows the hybridization of full-length C/EBP cDNA probe. The bottom panel shows the hybridization with the -actin probe as assessment of RNA quantities on each lane. Nuclear run-off assays. For run-on experiments, nuclei were harvested from NB4 cells before and after treatment with 5 × 10-7 mol/L 9-cis RA for 12 hours. Nuclei were isolated by resuspending the cells in 1 mL RSB solution (10 mmol/L Tris-HCl [pH 7.5], 10 mmol/L KCl, 3 mmol/L MgCl2 ) and adding 100 µL of 3% NP-40 (Sigma) for 10 minutes. After pelleting at 500g for 10 minutes at 4°C, the nuclei were resuspended at 108 nuclei/mL in nuclei storage buffer (40% glycerol, 50 mmol/L Tris-HCl [pH 8.3], 5 mmol/L MgCl2 , 0.1 mmol/L EDTA) and kept on ice. For each reaction, 200 µL of nuclei was incubated at 30°C for 20 minutes in 100 µL of run-on assay buffer (15 mmol/L Tris-HCl [pH 8.0]; 7.5 mmol/L MgCl2 ; 450 mmol/L KCl; 0.75 mmol/L each of ATP, GTP, and CTP; 1 U/µL RNasin [Promega, Madison, WI]; and 250 µCi -32P-UTP). RNase-free DNase I (3 U; Promega) was then added and the reaction was incubated for 5 minutes at 30°C. Digestion with 15 µg of proteinase K was performed at 37°C for 45 minutes in 1% SDS and 10 mmol/L EDTA. The RNA was then extracted, precipitated, and hydrolyzed as described.24 For the detection of run-on labeled transcripts on the dot blots, 10 µg of each cDNA plasmid (denatured by boiling in 0.3 mol/L NaOH and neutralized with 60 mmol/L Tris-HCl [pH 8.0] and 6× SSC) was applied to a nitrocellulose strip (MSI) in a dot blot apparatus. The immobilized plasmids were then washed with 500 µL of filtered 6× SSC. The filters were baked and prehybridized as for Northern blot analysis. For each reaction, equal counts of run-on labeled transcripts as purified by ProbeQuant G-50 micro-columns (Pharmacia, Piscataway, NJ) were hybridized at 106 cpm/mL for 36 hours at 42°C. Filters were washed to a stringency of 0.1× SSC at 55°C and exposed to Kodak Biomax film. Fold-inductions were calculated by the ratio of radioactive counts of C/EBP to -actin measured through Ambis Core Software, Version 4.0, according to the manufacturer's instructions (CSPI). Western blot analysis. Samples of total cell lysate (30 µg) were denatured by the addition of 2× electrophoresis sample buffer (120 mmol/L Tris-HCl [pH 6.8], 4% SDS, 25% glycerol, 3% -mercaptoethanol) and incubated for 10 minutes at 90°C. Samples were separated on a 15% polyacrylamide gel containing SDS.25 The proteins were electroblotted overnight onto Immobilon-P membrane as described by the manufacturer (Millipore, Bedford, MA). Purified rabbit polyclonal anti-C/EBP antibody (18 µg/mL)18 was incubated with the previously blocked membrane for 1 hour at room temperature, and bound antibody was detected using antirabbit horseradish peroxidase antibody conjugate and the ECL substrate according to the manufacturer's instructions (Amersham, Arlington Heights, IL). COS cells transfected with either a human C/EBP cDNA expression plasmid or empty vector were used as positive and negative controls, respectively.     RESULTS Abstract Introduction Methods Results Discussion References Accumulation of C/EBP mRNA during induction of differentiation of NB4 cells to granulocytes. The NB4 cells differentiated along the granulocytic pathway after exposure to 9-cis RA26,27; after exposure of these cells to 9-cis RA (10-7 mol/L for 6 days), 55% and 93% became NBT+ and CD11b+ as compared with less than 5% and less than 10%, respectively, in control NB4 cells (data not shown). Increased accumulation (1.6-fold) of C/EBP mRNA occurred as early as 1 hour after exposure of the NB4 cells to 9-cis RA (5 × 10-7 mol/L). By 48 hours after induction, C/EBP mRNA levels were 5.1-fold greater than the baseline (Fig 1A). Longer exposure of the retinoid did not result in increased levels of C/EBP mRNA (data not shown). Dose-response studies with NB4 cells induced with 9-cis RA showed that 10-7 to 10-6 mol/L 9-cis RA (12 hours) induced peak levels (5-fold) of C/EBP mRNA, but even 10-10 mol/L 9-cis RA increased levels of the transcripts by 1.4-fold (Fig 1B). View larger version (49K): [in this window] [in a new window]   View larger version (21K): [in this window] [in a new window]   View larger version (44K): [in this window] [in a new window]   View larger version (43K): [in this window] [in a new window]   Fig 3. (A) Rate of transcription of C/EBP in untreated NB4 cells (control) and NB4 cells induced for 12 hours with 9-cis RA (5 × 10-7 mol/L). Nuclei were isolated for run-off experiments as described in the Materials and Methods. Equivalent counts of 32P-labeled RNA transcripts were hybridized to plasmids immobilized on nitrocellulose membranes as indicated (MPO, full-length MPO cDNA in PUC vector; pcDNA, empty pcDNA vector; C/EBP, full-length C/EBP antisense cDNA in pcDNA vector; -actin, 3' UT -actin in PBR322 vector). (B) Half-life of mature C/EBP RNA in NB4 cells. Northern blot of total RNA (30 µg/lane) of NB4 cells exposed for 0 to 4 hours to actinomycin (10 µg/mL) with or without prior treatment with 9-cis RA as indicated. (C) Effect of a protein synthesis inhibitor on C/EBP RNA expression. Northern blot with total RNA (30 µg/lane) of NB4 cells treated either with 10 µg/mL CHX alone, with CHX (10 µg/mL) and 9-cis RA (5 × 10-7 mol/L), or with 9-cis RA (5 × 10-7 mol/L) alone. Cells were harvested at 0, 4, 6, and 8 hours. The top panel shows the hybridization with full-length C/EBP cDNA probe. The bottom panel shows the hybridization with -actin probe as assessment of RNA quantities on each lane. Fold-inductions were calculated by the ratio of densitometry readings of C/EBP to -actin. (D) Effect of ATRA on C/EBP protein expression in NB4 cells. NB4 cells were cultured with ATRA (5 × 10-7 mol/L) for different durations. Lysates were made from the cells and Western blotted. COS cells transfected with either a human C/EBP cDNA expression vector (lane +) or empty vector (lane -) were used as positive and negative controls, respectively. The arrow denotes C/EBP protein as seen by Western blot. Preexposure of NB4 cells to 5 × 10-7 mol/L ATRA for 30 minutes potentiated differentiation of NB4 by nonretinoids.26,28 For example, ATRA-priming (5 × 10-7 mol/L) and then the addition of either HMBA (2 mmol/L) or DMSO (1.25%, vol/vol) resulted in greater than 50% and greater than 90% NBT+ and CD11b+ cells, respectively (data not shown). RA-priming alone resulted in 14% NBT+ and 31% CD11b+ cells, respectively. This ATRA-priming alone increased the abundance of C/EBP fourfold after washing and culturing in regular medium for 3 days as compared with the control (Fig 2). Nonretinoids used alone did not alter the low levels of C/EBP transcripts. However, cells primed with ATRA and then treated with either HMBA or DMSO, both potent granulocytic-inducing agents,26,29 resulted in a greater than 8- to 10-fold increase in C/EBP transcript level. In contrast, both TPA and vitamin D3 induced NB4 cells to differentiate down the monocytic pathway.26,29,30 NB4 cells pulsed with ATRA for 30 minutes and then treated with either TPA (5 × 10-8 mol/L) or vit D3 (10-7 mol/L) for 3 days became adherent (>90% and >80%, respectively), as consistent with monocytic differentiation. ATRA-primed cells treated with TPA (5 × 10-8 mol/L) or 1,25(OH)2D3 (10-7 mol/L) for 3 days showed an approximately 10-fold reduction of C/EBP mRNA levels. Regulation of C/EBP mRNA expression in NB4 cells treated with 9-cis RA. To determine if 9-cis RA affected C/EBP expression at the level of initiation of transcription, nuclei both from NB4 induced with 9-cis RA (5 × 10-7 mol/L) for 12 hours and from untreated NB4 (as control) were isolated and subjected to run-off transcription assays. The rate of transcription of C/EBP genes in vivo, as shown by the amount of labeled RNA hybridizing to the full-length C/EBP cDNA on the dot blot (Fig 3A), was increased more than threefold in NB4 cells treated with 9-cis RA than the untreated NB4 control cells, as shown by radioactive counts (normalized with -actin). The half-life of C/EBP mRNA was measured by calculating the decay of RNA accumulation after transcription was blocked with actinomycin D (Fig 3B). Cumulative radioactive counting showed that the half-life of NB4 cells was approximately 2 hours in both the presence and absence of 9-cis RA treatment. To examine whether C/EBP mRNA induction by 9-cis RA was dependent on ongoing protein synthesis, NB4 cells were preincubated with cycloheximide (10 µg/mL) for 30 minutes and then treated with 9-cis RA (5 × 10-7 mol/L for 4, 6, and 8 hours). The data show that upregulation of the C/EBP mRNA by 9-cis RA occurred even in the absence of protein synthesis (Fig 3C). To examine whether the induction of C/EBP mRNA by 9-cis RA in NB4 cells is matched by the induction of the C/EBP protein, NB4 cells were cultured with ATRA (5 × 10-7 mol/L) for different durations. Cells were harvested and lysates were examined by Western blotting. Parallel to the increase of C/EBP mRNA, the C/EBP protein levels began to increase by 1 hour (Fig 3D). The maximum induction occurred by 24 hours (>5-fold). Accumulation of C/EBP mRNA during induction of differentiation of U937 cells to granulocytes. The U937 cells differentiated along the granulocytic pathway after exposure to ATRA.31,32 Radioactive counting showed that the level of C/EBP mRNA in U937 cells increased approximately twofold after 48 hours of ATRA-induction (Fig 4). View larger version (50K): [in this window] [in a new window]   Fig 4. Regulation of C/EBP expression in U937 cells by ATRA. Northern blot of total RNA (30 µg/lane) of U937 cells exposed for various lengths of time to ATRA (5 × 10-7 mol/L). The top panel shows the hybridization with full-length C/EBP cDNA probe, and the bottom panel shows the hybridization with -actin cDNA probe as assessment of RNA quantities in each lane. Accumulation of C/EBP mRNA during induction of differentiation of HL-60 cells to granulocytes. The HL-60 cells differentiated along the granulocytic pathway after exposure to DMSO and ATRA.22,33,34 For example, either ATRA (10-7 mol/L for 5 days) or DMSO (1.25% vol/vol for 5 days) induced NBT reduction (>60%) of HL-60 cells as compared with control HL-60 cells (5% NBT+; data not shown). The C/EBP mRNA level increased approximately twofold by 6 hours of ATRA-induction (Fig 5A). In contrast, C/EBP mRNA levels decreased after 2 hours of DMSO-induction and then increased to baseline levels after 24 to 72 hours (Fig 5B). View larger version (57K): [in this window] [in a new window]   View larger version (59K): [in this window] [in a new window]   Fig 5. (A) Regulation of C/EBP expression in HL60 cells by ATRA. Northern blot of total RNA (20 µg/lane) of HL60 cells exposed for various lengths of time to ATRA (5 × 10-7 mol/L). The top panel shows the hybridization with full-length C/EBP cDNA probe, and the bottom panel displays the hybridization with -actin cDNA probe as assessment of RNA quantities in each lane. (B) Regulation of C/EBP expression in HL60 cells by DMSO. Northern blot of total RNA (20 µg/lane) of HL60 cells exposed for various lengths of time to DMSO (1.25%). The top panel shows the hybridization with full-length C/EBP cDNA probe, and the bottom panel shows the hybridization with -actin cDNA probe as assessment of RNA quantities in each lane.     DISCUSSION Abstract Introduction Methods Results Discussion References Promyelocytic NB4, HL-60, and myelomonoblastic U937 cells were used to study the regulation of expression of C/EBP gene during their differentiation. We found that RA treatment increased the abundance of C/EBP mRNA approximately twofold in HL-60 and U937 cells and approximately fivefold in NB4 cells. Accumulation of C/EBP mRNA paralleled the increased granulocytic differentiation of the cells. This occurred most prominently in the NB4 cells. These findings paralleled our data33 and the data of others34 using fresh human hematopoietic cells. The early, normal hematopoietic stem cell (CD34+/CD33-) had very weak expression of C/EBP; the CD34+/CD33+ more mature myeloid stem cell expressed slightly more C/EBP. As the cells differentiated to promyelocytes, myelocytes, metamyelocytes, and granulocytes, levels of C/EBP mRNA obtained a plateau elevated level. In contrast, monocyte and macrophages had very low levels of expression; and in erythroid cells, C/EBP was undetectable. Taken together, these results suggest an important function for C/EBP at the myeloblast/promyelocyte stage of granulocyte differentiation. Analysis of C/EBP deletional mice will further help determine the role of C/EBP in hematopoiesis. The contribution of transcription and mRNA stability to the increase in steady-state levels of C/EBP observed in retinoid-stimulated NB4 cells was examined. Stability of the C/EBP transcripts as assayed by measuring the decay of message in the presence of actinomycin D showed no change during 9-cis RA-mediated differentiation of NB4 cells to granulocytes. Rate of transcription of the C/EBP gene was also measured from nuclei isolated from both untreated NB4 and NB4 cells induced with 9-cis RA. The retinoid (5 × 10-7 mol/L) increased the rate of transcription of C/EBP by approximately threefold at 12 hours, consistent with the level of induction of C/EBP mRNA observed by Northern analysis. Also, ATRA-induction of NB4 cells resulted in a peak fivefold induction of C/EBP protein at 24 hours, paralleling the increase in the transcript levels. The fact that they stimulated accumulation of C/EBP mRNA in the absence of new protein synthesis is further evidence to suggest that retinoids have a direct effect on transcription of C/EBP. The enhancement in accumulation of C/EBP mRNA by retinoids may not merely be a reflection of granulocytic differentiation, because HL-60 cells cultured with DMSO undergo granulocytic differentiation,35,36 but levels of C/EBP mRNA at least initially decreased rather than increased. These studies suggest strongly for transcriptional control of C/EBP via a retinoid acid response element. Could the prominent induction of expression of C/EBP mNRA observed in NB4 be unique to this cell type? The cell line NB4 was established from the leukemia cells of a patient with acute promyelocytic leukemia27 and the cells contain the pathognomic chromosomal rearrangement t(15; 17) resulting in the PML-RAR fusion gene.37-39 This PML-RAR fusion product has been suggested to block or interfere with transcription of genes critical to myeloid differentiation, perhaps by sequestering the RAR in nonfunctional locations as shown by a nuclear speckled pattern of the fusion protein.40 High concentrations of retinoic acid allow the RAR fusion protein to assume a more typical RAR nuclear location. It is possible that the retinoid-PML/RAR complex more readily binds and transactivates the C/EBP gene because retinoids had only a moderate enhancement of C/EBP in HL-60 and U937 cells, even though the ligand induced granulocytic differentiation of these cells similar to NB4. Another explanation for the prominent effect of retinoids in NB4 could relate to expression of other transcriptional factors that combinatorially interact with the RA/RAR to activate C/EBP. Furthermore, cells that normally cannot express C/EBP, such as early erythroblastic K562 cells, cannot be induced by RA to express C/EBP,18 suggesting that modulation of the gene in the cells requires more than retinoid ligand and its receptor. Further studies using NB4 and HL-60 cell lines that are resistant to retinoids as well as functional analysis of a potential retinoic acid response element in the C/EBP gene are required.     FOOTNOTES    Submitted December 19, 1996; accepted June 5, 1997.    Supported by National Institutes of Health grants and also in part by the Concern Foundation and the Parker Hughes Trust. H.P.K. is a member of the UCLA Jonsson Comprehensive Cancer Center and holds an endowed Mark Goodson Chair of Oncology Research at Cedars-Sinai Medical Center/UCLA School of Medicine. D.Y.C. is a recipient of a Medical Scientist Training Grant (No. GM08042) from the National Institutes of Health.    Address reprint requests to H. Phillip Koeffler, MD, Director, Division of Hematology/Oncology, Professor of Medicine, UCLA, 8700 Beverly Blvd, B-213, Los Angeles, CA 90048.    The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hearly marked ``advertisment'' in accordance with 18 U.S.C. section 1734 solely to indicate this fact.     ACKNOWLEDGMENT The authors thank Carl W. Miller for his helpful technical advice.     REFERENCES Abstract Introduction Methods Results Discussion References 1. Friedman AD: Regulation of immature myeloid cell differentiation by PEPB2/CBP, myb, C/EBP and Ets family members. Curr Top Microbiol Immunol 211:149, 1996[Medline] [Order article via Infotrieve] 2. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG: CCAAT enhancer binding protein (C/EBP) and AML1 (CBF alpha 2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16:1231, 1996[Abstract] 3. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A: Myb and NF-M: Combinatorial acticvators of myeloid genes in heterologous cell types. Genes Dev 7:749, 1993[Abstract/Free Full Text] 4. Simon MC, Olson M, Scott E, Hack A, Su G, Singh H: Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr Top Microbiol Immunol 211:113, 1996[Medline] [Order article via Infotrieve] 5. Lubbert M, Herrmann F, Koeffler HP: Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood 77:909, 1991[Free Full Text] 6. Nichols J, Nimer SD: Transcriptional factors, translocations and leukemia. Blood 80:2953, 1992[Abstract/Free Full Text] 7. Simon TH: Chromosomal translocations in human cancer. Nature 372:143, 1994[Medline] [Order article via Infotrieve] 8. Akira S, Isshik H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T: A nuclear factor for IL-6 expression (NF-IL6) is a member of C/EBP family. EMBO J 9:1897, 1990[Medline] [Order article via Infotrieve] 9. Juan TS, Wilson DR, Wilde MD, Darlington GJ: Participation of the transcription factor C/EBP delta in acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci USA 90:2584, 1993[Abstract/Free Full Text] 10. Poli V, Mancini FP, Cortese R: IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63:643, 1990[Medline] [Order article via Infotrieve] 11. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ: Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269:1108, 1995[Abstract/Free Full Text] 12. Scott LM, Civin CI, Rorth P, Friedman AD: A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725, 1992[Abstract/Free Full Text] 13. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T: Targeted disruption of the NF-IL6 gene discloses its essential role in bacterial killing and tumor cytotoxicity by macrophages. Cell 80:353, 1995[Medline] [Order article via Infotrieve] 14. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG: Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94:569, 1997[Abstract/Free Full Text] 15. Roman C, Platero JS, Shuman JD, Calame K: Ig/EBP-1: A ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev 4:1404, 1990[Abstract/Free Full Text] 16. Davydov IV, Bohmann D, Krammer PH, Li-Weber M: Cloning of the cDNA encoding human C/EBP gamma, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter. Gene 161:271, 1995[Medline] [Order article via Infotrieve] 17. Antonson P, Stellan B, Yamanaka R, Xanthopoulos KG: A novel human CCAAT/enhancer binding protein gene, C/EBP, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor / locus. Genomics 35:30, 1996[Medline] [Order article via Infotrieve] 18. Chumakov AM, Grillier I, Chumakova E, Chih D, Slater J, Koeffler HP: Cloning of the novel human myeloid-specific C/EBP transcription factor (C/EBP). Mol Cell Biol 17:1375, 1997[Abstract] 19. Shuman JD, Vinson CR, McKnight SL: Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP. Science 249:771, 1990[Abstract/Free Full Text] 20. Vinson CR, Sigler PB, McKnight SL: Scissors-grips model for DNA recognition by a family of leucine zipper proteins. Science 246:911, 1989[Abstract/Free Full Text] 21. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC: Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentaition by dimethylsulfoxide. J Exp Med 149:969, 1979[Abstract/Free Full Text] 22. Elstner E, Linker-Israeli M, Le J, Grillier I, Said J, Shintaku P, Krajewski S, Reed JC, Binderup L, Koeffler HP: Combination of potent 20-epi-vitamin D3 analog (KH1060) and 9-cis-retinoic acid inhibits irreversibly clonal growth, decreases bcl-2 expression and induces apoptosis in HL-60 leukemic cells. Cancer Res 56:3570, 1996[Abstract/Free Full Text] 23. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989 24. Greenberg ME: Identification of newly transcribed RNA, in Ausubel FM (ed): Current Protocols in Molecular Biology. New York, NY, Wiley & Sons, 1988, p 4.10.1 25. Selsted ME, Miller CW, Novotny MJ, Morris WL, Koeffler HP: Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels. Blood 82:1317, 1993[Abstract/Free Full Text] 26. Chen A, Licht JD, Wu Y, Hellinger N, Scher W, Waxman S: Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood 84:2122, 1994[Abstract/Free Full Text] 27. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation-inducible cell line with t(15; 17) marker isolated from a humanacute promyelocytic leukemia (M3). Blood 77:1080, 1991[Abstract/Free Full Text] 28. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M: Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA 91:8428, 1994[Abstract/Free Full Text] 29. Khana-Gupta A, Kolibaba K, Zibello TA, Berliner N: NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 84:294, 1994[Abstract/Free Full Text] 30. Bhatia M, Kirkland JB, Meckling-Gill KA: M-CSF and 1,25-dihydroxy vitamin D3 synergize with 12-O-tetradecanoylphorbal-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells. Leukemia 8:1744, 1994[Medline] [Order article via Infotrieve] 31. Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I: Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88:114, 1996[Abstract/Free Full Text] 32. Olsson IL, Breitman TR: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3',5'-monophosphate-inducing agents. Cancer Res 42:3924, 1982[Abstract/Free Full Text] 33. Morosetti R, Park D, Chumakov A, Shiohara M, Gombart A, Nakamaki T, Weinberg K, Koeffler P: A novel, myeloid-specific transcription factor, C/EBP, is upregulated during granulocytic but not monocytic differentiation. Blood (in press) 34. Yamaka R, Kim GD, Radomska H, Lekstrom-Himes J, Smith L, Antonson P, Tenen D, Xanthopoulos G: CCAAT/enhancer binding protein is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94:6462, 1997[Abstract/Free Full Text] 35. Collins SJ: The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation and cellular oncogene expression. Blood 70:1233, 1987[Abstract/Free Full Text] 36. Takeuchi T, Nakajima M, Morimoto K: Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis 17:1543, 1996[Abstract/Free Full Text] 37. de The H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature 347:558, 1990[Medline] [Order article via Infotrieve] 38. Borrow J, Goddard AD, Sheer D, Solomon E: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577, 1990[Abstract/Free Full Text] 39. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991[Medline] [Order article via Infotrieve] 40. Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillermin MC, Degos L, Chomienne C, de The H: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858, 1993[Abstract/Free Full Text] © 1997 by The American Society of Hematology. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: R. Bedi, J. Du, A. K. Sharma, I. Gomes, and S. J. Ackerman Human C/EBP-{epsilon} activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation Blood, January 8, 2009; 113(2): 317 - 327. [Abstract] [Full Text] [PDF] A. F. Gombart, J. Grewal, and H. P. Koeffler ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBP{epsilon} and C/EBP{alpha} J. Leukoc. Biol., June 1, 2007; 81(6): 1535 - 1547. [Abstract] [Full Text] [PDF] S. Agrawal, W.-K. Hofmann, N. Tidow, M. Ehrich, D. v. d. Boom, S. Koschmieder, W. E. Berdel, H. Serve, and C. Muller-Tidow The C/EBP{delta} tumor suppressor is silenced by hypermethylation in acute myeloid leukemia Blood, May 1, 2007; 109(9): 3895 - 3905. [Abstract] [Full Text] [PDF] A. Lennartsson, K. Vidovic, M. B. Pass, J. B. Cowland, and U. Gullberg All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBP{beta} and C/EBP{epsilon} to the BPI promoter J. Leukoc. Biol., July 1, 2006; 80(1): 196 - 203. [Abstract] [Full Text] [PDF] E. A. Williamson, I. K. Williamson, A. M. Chumakov, A. D. Friedman, and H. P. Koeffler CCAAT/enhancer binding protein {epsilon}: changes in function upon phosphorylation by p38 MAP kinase Blood, May 15, 2005; 105(10): 3841 - 3847. [Abstract] [Full Text] [PDF] J. Kim, S. Sharma, Y. Li, E. Cobos, J. J. Palvimo, and S. C. Williams Repression and Coactivation of CCAAT/Enhancer-binding Protein {epsilon} by Sumoylation and Protein Inhibitor of Activated STATx Proteins J. Biol. Chem., April 1, 2005; 280(13): 12246 - 12254. [Abstract] [Full Text] [PDF] S. Gery, D. J. Park, P. T. Vuong, D. Y. Chih, N. Lemp, and H. P. Koeffler Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes Blood, December 15, 2004; 104(13): 3911 - 3917. [Abstract] [Full Text] [PDF] Y. Jing, L. Xia, and S. Waxman Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia Blood, July 18, 2002; 100(3): 1008 - 1013. [Abstract] [Full Text] [PDF] H. Nakajima and J. N. Ihle Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein {epsilon} Blood, August 15, 2001; 98(4): 897 - 905. [Abstract] [Full Text] [PDF] A. F. Gombart, M. Shiohara, S. H. Kwok, K. Agematsu, A. Komiyama, and H. P. Koeffler Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-{epsilon} Blood, May 1, 2001; 97(9): 2561 - 2567. [Abstract] [Full Text] [PDF] P. Kastner, H. J. Lawrence, C. Waltzinger, N. B. Ghyselinck, P. Chambon, and S. Chan Positive and negative regulation of granulopoiesis by endogenous RAR{alpha} Blood, March 1, 2001; 97(5): 1314 - 1320. [Abstract] [Full Text] [PDF] T. Kubota, S. Kawano, D. Y. Chih, Y. Hisatake, A. M. Chumakov, H. Taguchi, and H. P. Koeffler Representational difference analysis using myeloid cells from C/EBPepsilon deletional mice Blood, December 1, 2000; 96(12): 3953 - 3957. [Abstract] [Full Text] [PDF] T. Ikezoe, E. S. Daar, J.-i. Hisatake, H. Taguchi, and H. P. Koeffler HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells Blood, November 15, 2000; 96(10): 3553 - 3559. [Abstract] [Full Text] [PDF] Y. Du, S. Tsai, J. R. Keller, and S. C. Williams Identification of an Interleukin-3-regulated Aldoketo Reductase Gene in Myeloid Cells Which May Function in Autocrine Regulation of Myelopoiesis J. Biol. Chem., March 15, 2000; 275(10): 6724 - 6732. [Abstract] [Full Text] [PDF] Y. Yamaguchi, H. Nishio, K. Kishi, S. J. Ackerman, and T. Suda C/EBPbeta and GATA-1 Synergistically Regulate Activity of the Eosinophil Granule Major Basic Protein Promoter: Implication for C/EBPbeta Activity in Eosinophil Gene Expression Blood, August 15, 1999; 94(4): 1429 - 1439. [Abstract] [Full Text] [PDF] A. Melnick and J. D. Licht Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Blood, May 15, 1999; 93(10): 3167 - 3215. [Full Text] [PDF] W. Verbeek, A. F. Gombart, A. M. Chumakov, C. Muller, A. D. Friedman, and H. P. Koeffler C/EBP{varepsilon} Directly Interacts With the DNA Binding Domain of c-myb and Cooperatively Activates Transcription of Myeloid Promoters Blood, May 15, 1999; 93(10): 3327 - 3337. [Abstract] [Full Text] [PDF] J. Lekstrom-Himes and K. G. Xanthopoulos CCAAT/Enhancer Binding Protein varepsilon  Is Critical for Effective Neutrophil-Mediated Response to Inflammatory Challenge Blood, May 1, 1999; 93(9): 3096 - 3105. [Abstract] [Full Text] [PDF] M. Shiohara, M. I. Dawson, P. D. Hobbs, N. Sawai, T. Higuchi, K. Koike, A. Komiyama, and H. P. Koeffler Effects of Novel RAR- and RXR-Selective Retinoids on Myeloid Leukemic Proliferation and Differentiation In Vitro Blood, March 15, 1999; 93(6): 2057 - 2066. [Abstract] [Full Text] [PDF] J. Lekstrom-Himes and K. G. Xanthopoulos Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors J. Biol. Chem., October 30, 1998; 273(44): 28545 - 28548. [Abstract] [Full Text] [PDF] E. A. Williamson, H. N. Xu, A. F. Gombart, W. Verbeek, A. M. Chumakov, A. D. Friedman, and H. P. Koeffler Identification of Transcriptional Activation and Repression Domains in Human CCAAT/Enhancer-binding Protein epsilon J. Biol. Chem., June 12, 1998; 273(24): 14796 - 14804. [Abstract] [Full Text] [PDF] J.-G. Tang and H. P. Koeffler Structural and Functional Studies of CCAAT/Enhancer-binding Protein epsilon J. Biol. Chem., May 18, 2001; 276(21): 17739 - 17746. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chih, D. Y. Articles by Koeffler, H. P. Search for Related Content PubMed PubMed Citation Articles by Chih, D. Y. Articles by Koeffler, H. P. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?

	Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020